Several highly esteemed Institutes such as the Mayo Clinic and CONICET have identified critical elements contributing to the aggressiveness of Pancreatic cancer. The survival rate
Moderna and Merck have announced promising five-year data for a groundbreaking personalized cancer treatment that combines mRNA technology with immunotherapy to prevent melanoma from returning
As reported on Science Daily, a breast cancer vaccine tested more than 20 years ago is drawing renewed scientific interest after researchers discovered that every
Editor’s Note: Patient Worthy is honored to share part 2 in an ongoing 10-part series, written and shared with us by Elena Genik. Before the
Cancer immunotherapy represents one of modern medicine’s greatest achievements, yet it’s also one of its most frustrating paradoxes: a treatment that works miracles for some
As reported on BioSpace, Moderna has entered a commercialization partnership with Italy‑based Recordati to support the development of mRNA‑3927, an investigational mRNA therapy for propionic
Osteosarcoma is a diagnosis no family should ever have to face. It is the most common primary bone cancer in children and adolescents, yet treatment
A groundbreaking genetic study published in The Journal of Clinical Endocrinology & Metabolism and reported by ScienceDaily.com has revealed that obesity and high blood pressure
Twenty years is a long time to believe a cancer chapter has closed. For two decades after my radical prostatectomy, I lived with the quiet
Editor’s Note: Patient Worthy is honored to share part 1 in an ongoing 10-part series, written and shared with us by Elena Genik. When Everything
A growing body of research shows that sleep quality, dietary sodium, and hypertension are more closely linked than once believed — and two major healthcare
Vera Therapeutics announced a major milestone in drug development on January 7, 2026, when the U.S. Food and Drug Administration granted Priority Review to the
As reported by the European Pharmacy Review, a combination approach using Johnson & Johnson’s small‑molecule therapy Caplyta (lumateperone) alongside standard antidepressants continues to show promising
A newly published Phase 1/2 study in The New England Journal of Medicine, and reported on by the Manila Times, highlights promising early results for tividenofusp
A New Approach to a Persistent Problem Celcuity has reached a critical inflection point in its pursuit of a novel breast cancer treatment. The FDA’s
As reported on Healio, glucagon-like peptide-1 (GLP-1)–based therapies are rapidly reshaping the landscape of diabetes and chronic kidney disease (CKD) management. Originally developed for glycemic
Immunoglobulin A nephropathy (IgAN) remains one of the most common primary glomerular diseases worldwide, yet effective treatments are limited. A new study, recently published in
If you got past the title without rolling your eyes or getting angry (I understand if you did either or both as you will see
The European Medicines Agency had endorsed the first immunotherapy option for advanced anal cancer. Read more here:
patientworthy.com/2026/02/05/ema-endorses-first-immunotherapy-option-for-advanced-anal-cancer/
From our friends@Amyloidosis Foundation #supportgroup𝕎𝕖'𝕣𝕖 𝕙𝕒𝕡𝕡𝕪 𝕥𝕠 𝕒𝕟𝕟𝕠𝕦𝕟𝕔𝕖 𝕠𝕦𝕣 𝕗𝕚𝕣𝕤𝕥 𝕡𝕒𝕥𝕚𝕖𝕟𝕥 𝕤𝕦𝕡𝕡𝕠𝕣𝕥 𝕘𝕣𝕠𝕦𝕡 𝕞𝕖𝕖𝕥𝕚𝕟𝕘 𝕠𝕗 𝟚𝟘𝟚𝟞!
Our speakers will be:
Dr. Muhamed Baljevic, Hematologist and VAMP Provider
Dr. Baljevic will present AL/Light Chain Updates from the American Society of Hematology
Jessie Parker, AL Patient, who will share her personal journey!
𝑫𝒂𝒕𝒆: 𝑭𝒆𝒃𝒓𝒖𝒂𝒓𝒚 𝟐𝟏, 𝟐𝟎𝟐𝟔
𝑻𝒊𝒎𝒆: 𝟏𝟐:𝟎𝟎𝒑𝒎 - 𝟐:𝟎𝟎𝒑𝒎
𝑳𝒐𝒄𝒂𝒕𝒊𝒐𝒏: 𝑫𝒆𝒍 𝑭𝒓𝒊𝒔𝒄𝒐 𝑮𝒓𝒊𝒍𝒍𝒆
𝟏𝟐𝟎𝟏 𝑫𝒆𝒎𝒐𝒏𝒃𝒓𝒆𝒖𝒏 𝑺𝒕.
𝑵𝒂𝒔𝒉𝒗𝒊𝒍𝒍𝒆, 𝑻𝑵 𝟑𝟕𝟐𝟎𝟑
Parking garage entrances are both just before and just after the restaurant entrance-please bring your parking ticket with you to be validated.
Please join us for a very nice lunch, great conversation and information sharing. Please feel friend to bring guests. The Amyloidosis Foundation covers events w/the help of several sponsors, so there is never a cost to attend. And, this is a great way to help spread knowledge on this challenging disease!
RSVP as soon as possible to: Adrienne Molteni at [email protected] or 615-497-1770.
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
